RANDOMIZED TRIAL OF LIMUS-ELUTING STENTS WITH BIODEGRADABLE OR PERMANENT POLYMER COATINGS REGARDING STENT COVERAGE ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY.

Trial Profile

RANDOMIZED TRIAL OF LIMUS-ELUTING STENTS WITH BIODEGRADABLE OR PERMANENT POLYMER COATINGS REGARDING STENT COVERAGE ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2014

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms TEST-6-OCT
  • Most Recent Events

    • 04 Jan 2012 Actual patient number is 48 according to ClinicalTrials.gov.
    • 04 Jan 2012 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
    • 04 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top